Squarepoint’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Sell |
13,322
-10,445
| -44% | -$115K | ﹤0.01% | 2411 |
|
|
2025
Q1 | $212K | Sell |
23,767
-23,401
| -50% | -$209K | ﹤0.01% | 2339 |
|
|
2024
Q4 | $444K | Sell |
47,168
-51,783
| -52% | -$487K | ﹤0.01% | 1995 |
|
|
2024
Q3 | $798K | Sell |
98,951
-17,305
| -15% | -$139K | ﹤0.01% | 1536 |
|
|
2024
Q2 | $986K | Buy |
+116,256
| New | +$986K | ﹤0.01% | 1381 |
|
|
2024
Q1 | – | Sell |
-52,054
| Closed | -$585K | – | 2920 |
|
|
2023
Q4 | $585K | Buy |
+52,054
| New | +$585K | ﹤0.01% | 1606 |
|
|
2023
Q3 | – | Sell |
-48,706
| Closed | -$504K | – | 2847 |
|
|
2023
Q2 | $504K | Sell |
48,706
-1,070
| -2% | -$11.1K | ﹤0.01% | 1594 |
|
|
2023
Q1 | $540K | Sell |
49,776
-18,503
| -27% | -$201K | ﹤0.01% | 1434 |
|
|
2022
Q4 | $766K | Buy |
68,279
+13,553
| +25% | +$152K | ﹤0.01% | 1240 |
|
|
2022
Q3 | $555K | Buy |
54,726
+35,741
| +188% | +$362K | ﹤0.01% | 1364 |
|
|
2022
Q2 | $172K | Buy |
+18,985
| New | +$172K | ﹤0.01% | 1779 |
|
|
2022
Q1 | – | Sell |
-15,971
| Closed | -$176K | – | 2803 |
|
|
2021
Q4 | $176K | Sell |
15,971
-19,255
| -55% | -$212K | ﹤0.01% | 2146 |
|
|
2021
Q3 | $261K | Buy |
+35,226
| New | +$261K | ﹤0.01% | 1691 |
|
|
2020
Q4 | – | Sell |
-49,919
| Closed | -$738K | – | 2869 |
|
|
2020
Q3 | $738K | Buy |
49,919
+38,069
| +321% | +$563K | 0.01% | 1104 |
|
|
2020
Q2 | $249K | Buy |
+11,850
| New | +$249K | ﹤0.01% | 1662 |
|
|
2019
Q4 | – | Sell |
-49,622
| Closed | -$967K | – | 2668 |
|
|
2019
Q3 | $967K | Sell |
49,622
-6,439
| -11% | -$125K | 0.01% | 1230 |
|
|
2019
Q2 | $915K | Buy |
56,061
+38,656
| +222% | +$631K | 0.01% | 1297 |
|
|
2019
Q1 | $395K | Buy |
+17,405
| New | +$395K | ﹤0.01% | 1584 |
|
|
2016
Q3 | – | Sell |
-12,300
| Closed | -$279K | – | 1248 |
|
|
2016
Q2 | $279K | Buy |
+12,300
| New | +$279K | 0.02% | 772 |
|